Initial depression severity and response to antidepressants v. placebo: patient-level data analysis from 34 randomised controlled trials.

Rabinowitz, Jonathan; Werbeloff, Nomi; Mandel, Francine S; Menard, François; Marangell, Lauren; Kapur, Shitij

Rabinowitz, Jonathan; Werbeloff, Nomi; Mandel, Francine S; Menard, François; Marangell, Lauren; Kapur, Shitij.

Afiliação

Rabinowitz J; Jonathan Rabinowitz, PhD, Nomi Werbeloff, PhD, School of Social Work, Ramat Gan, Bar Ilan University, Israel; Francine S. Mandel, PhD, Pfizer Development Operations, New York, USA; François Menard, MD, Lundbec Research Department, Paris, France; Lauren Marangell, MD, Department of Psychiatry, Univer
Werbeloff N; Jonathan Rabinowitz, PhD, Nomi Werbeloff, PhD, School of Social Work, Ramat Gan, Bar Ilan University, Israel; Francine S. Mandel, PhD, Pfizer Development Operations, New York, USA; François Menard, MD, Lundbec Research Department, Paris, France; Lauren Marangell, MD, Department of Psychiatry, Univer
Mandel FS; Jonathan Rabinowitz, PhD, Nomi Werbeloff, PhD, School of Social Work, Ramat Gan, Bar Ilan University, Israel; Francine S. Mandel, PhD, Pfizer Development Operations, New York, USA; François Menard, MD, Lundbec Research Department, Paris, France; Lauren Marangell, MD, Department of Psychiatry, Univer
Menard F; Jonathan Rabinowitz, PhD, Nomi Werbeloff, PhD, School of Social Work, Ramat Gan, Bar Ilan University, Israel; Francine S. Mandel, PhD, Pfizer Development Operations, New York, USA; François Menard, MD, Lundbec Research Department, Paris, France; Lauren Marangell, MD, Department of Psychiatry, Univer
Marangell L; Jonathan Rabinowitz, PhD, Nomi Werbeloff, PhD, School of Social Work, Ramat Gan, Bar Ilan University, Israel; Francine S. Mandel, PhD, Pfizer Development Operations, New York, USA; François Menard, MD, Lundbec Research Department, Paris, France; Lauren Marangell, MD, Department of Psychiatry, Univer
Kapur S; Jonathan Rabinowitz, PhD, Nomi Werbeloff, PhD, School of Social Work, Ramat Gan, Bar Ilan University, Israel; Francine S. Mandel, PhD, Pfizer Development Operations, New York, USA; François Menard, MD, Lundbec Research Department, Paris, France; Lauren Marangell, MD, Department of Psychiatry, Univer

Br J Psychiatry ; 209(5): 427-428, 2016 11.

Article em En | MEDLINE | ID: mdl-27198482

Assuntos

Transtorno Depressivo Maior/tratamento farmacológico; Avaliação de Resultados da Assistência ao Paciente; Efeito Placebo; Ensaios Clínicos Controlados Aleatórios como Assunto/estatística & dados numéricos; Sistema de Registros/estatística & dados numéricos; Índice de Gravidade de Doença; Antidepressivos de Segunda Geração; Humanos

Buscar no Google

Imprimir

XML

PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Índice de Gravidade de Doença / Efeito Placebo / Ensaios Clínicos Controlados Aleatórios como Assunto / Sistema de Registros / Transtorno Depressivo Maior / Avaliação de Resultados da Assistência ao Paciente Tipo de estudo: Clinical_trials / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Buscar no Google

Imprimir

XML

PubMed Links